MicrofluidX receives Innovate UK grant to advance cell and gene therapy technology platform

U.K- based Cell and gene therapy (CGT) technology developer MicrofluidX has received a £685,000 ($872,000 USD) grant from Innovate UK enabling the company to advance development of its stackable multi-bioreactor technology, Cyto Engine Stack. The grant was awarded via the Innovate UK Investor Partnerships Future Economy program award. The lead investor partner of the program is Longwall Ventures.

MicrofluidX said it will use the funding to progress the first-generation prototypes of this concept, as well as continuing to develop the Cyto Engine platform for process development. The company anticipates the first Cyto Engine product to be launched in early 2025.